OPPM
PRTK
Opus Point Partners Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-18,000
| Closed | -$175K | – | 44 |
|
2018
Q3 | $175K | Sell |
18,000
-2,000
| -10% | -$19.4K | 0.42% | 44 |
|
2018
Q2 | $204K | Hold |
20,000
| – | – | 0.44% | 46 |
|
2018
Q1 | $260K | Sell |
20,000
-20,000
| -50% | -$260K | 0.51% | 44 |
|
2017
Q4 | $716K | Hold |
40,000
| – | – | 0.62% | 34 |
|
2017
Q3 | $1M | Hold |
40,000
| – | – | 0.9% | 31 |
|
2017
Q2 | $964K | Sell |
40,000
-40,000
| -50% | -$964K | 0.88% | 31 |
|
2017
Q1 | $1.54M | Hold |
80,000
| – | – | 1.14% | 28 |
|
2016
Q4 | $1.23M | Hold |
80,000
| – | – | 0.98% | 29 |
|
2016
Q3 | $1.04M | Buy |
80,000
+42,335
| +112% | +$551K | 0.58% | 28 |
|
2016
Q2 | $524K | Sell |
37,665
-7,335
| -16% | -$102K | 0.51% | 33 |
|
2016
Q1 | $683K | Sell |
45,000
-15,000
| -25% | -$228K | 0.53% | 39 |
|
2015
Q4 | $1.14M | Buy |
+60,000
| New | +$1.14M | 0.75% | 37 |
|